| William G Sybesma, MD | |
|
865 Mullen Dr, Fond Du Lac, WI 54935-6437 | |
| (920) 744-8147 | |
| Not Available |
| Full Name | William G Sybesma |
|---|---|
| Gender | Male |
| Speciality | Otolaryngology |
| Location | 865 Mullen Dr, Fond Du Lac, Wisconsin |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093798324 | NPI | - | NPPES |
| 040008752 | Other | WI | RAILROAD MEDICARE |
| 39080723648 | Other | WI | UNITY |
| WI0156 | Other | WI | JOHN DEERE |
| 30172100 | Medicaid | WI | |
| 12573 | Other | WI | DEAN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Y00000X | Otolaryngology | 21464 (Wisconsin) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| William G Sybesma, MD 865 Mullen Dr, Fond Du Lac, WI 54935-6437 Ph: (920) 744-4187 | William G Sybesma, MD 865 Mullen Dr, Fond Du Lac, WI 54935-6437 Ph: (920) 744-8147 |
News Archive
The genes BRCA1 and BRCA2 play a significant role in hereditary breast and ovarian cancers. Recent media attention has focused on American actress Angelina Jolie's decision to have her ovaries and fallopian tubes surgically removed after genetic testing for such cancers.
TTP plc, a leading independent technology and product development company, today announced it has established a partnership with NHS Highland and The University of the Highlands and Islands, to use clinical data interpretation and machine learning algorithms to predict which patients with atrial fibrillation are able to be successfully treated using electrical cardioversion.
HRA Pharma announced today that the US Food and Drug Administration (FDA) granted approval for ella(R) (ulipristal acetate) as a prescription-only emergency contraceptive indicated for use within 120 hours (five days) of unprotected intercourse or a known or suspected contraceptive failure. ella is not intended for routine use as a contraceptive.
Ohr Pharmaceutical, a pharmaceutical company focused on the development of novel therapeutics for large unmet medical needs, and leading global cancer research center Cold Spring Harbor Laboratory (CSHL) today announced the establishment of DepYmed Inc., a new joint venture to develop trodusquemine and related analogs.
› Verified 6 days ago
John J Nash, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 421 Camelot Dr, Fond Du Lac, WI 54935 Phone: 920-926-8460 | |
Suhail M Hariri, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 421 Camelot Dr, Fond Du Lac, WI 54935 Phone: 920-926-8460 |